U.S. market Closed. Opens in 2 days 1 hour 50 minutes

CMND | Clearmind Medicine Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-10-312022-10-312021-10-312020-10-312019-10-312018-10-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue56.34K113.38K2.57KN/AN/AN/A
Gross Profit-56.34K-113.38K-2.57KN/AN/AN/A
Operating Expenses8.74M8.53M3.68M233.22K105.28K254.53K
Selling, General & Admin6.60M5.43M3.03M233.22K105.28K254.53K
Research & Development2.14M2.98M646.49KN/AN/AN/A
Other Operating ExpensesN/A113.38KN/AN/AN/A60.00K
Operating Income-8.74M-8.53M-3.45M-233.22K-105.28K-254.53K
Other Expenses / Income-3.19M-837.47K-446.44K-179.69K-3.0060.00K
Before Tax Income-11.93M-9.37M-3.90M-233.22K-105.28K-194.53K
Income Tax Expenses24.09K40.75K223.22K-385.99K-171.86K-60.00K
Net Income-11.96M-9.41M-4.12M-233.22K-105.28K-194.53K
Interest ExpensesN/A19.68KN/AN/AN/AN/A
Basic Shares Outstanding202.00K43.33K30.91K18.13K12.33K10.78K
Diluted Shares Outstanding202.48K43.33K30.91K18.13K12.33K10.78K
EBITDA-8.71M-8.42M-3.45M-233.22K-105.28K-254.53K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-11.93M-9.35M-3.90M-619.21K-277.15K-254.53K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-10-312022-10-312021-10-312020-10-312019-10-312018-10-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙